Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 13.

Article

Lattmann, Eric; Billington, David C.; Poyner, David; Howitt, Stephen B. and Offel, Michael (2001). Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists. Drug Design and Discovery, 17 (3), pp. 219-230.

Coulson, Judy M.; Poyner, David; Chantry, Andrew; Irwin, William J. and Akhtar, Saghir (1996). A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells. Molecular Pharmacology, 50 (2), pp. 314-325.

Gosling, M.; Poyner, David and Smith, J.W. (1996). Effects of arachidonic acid upon the volume-sensitive chloride current in rat osteoblast-like (ROS 17/2.8) cells. Journal of Physiology, 493 (3), pp. 613-623.

Tomlinson, A. Elaine and Poyner, David (1996). Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens. British Journal of Pharmacology, 117 (6), pp. 1362-1368.

Hay, Debbie L.; Poyner, David and Dickerson, Ian CGRP receptor heterogeneity:a role for receptor component protein? Trends in Endocrinology and Metabolism, 14 (1), pp. 3-4.

Foster, Alexander J.; Bird, Roger A.; Kelly, Steven L.; Nishimura, Kazuko; Poyner, David; Taylor, Stephen and Smith, Stephen N. FITC-lectin avidity of Cryptococcus neoformans cell wall and capsular components. Mycologia, 96 (1), pp. 1-8.

Weston, Cathryn; Lu, Jing; Li, Naichang; Barkan, Kerry; Richards, Gareth O.; Roberts, David J.; Skerry, Timothy M.; Poyner, David; Pardamwar, Meenakshi; Reynolds, Christopher A.; Dowell, Simon J.; Willars, Gary B. and Ladds, Graham Modulation of glucagon receptor pharmacology by Receptor Activity-modifying Protein-2 (RAMP2). Journal of Biological Chemistry, 290 (38), pp. 23009-23022.

Akhtar, Saghir; Dunnion, Debbie; Poyner, David; Ackroyd, John; Bibby, Mike and Double, John Sequence and chemistry requirements for a novel aptameric oligonucleotide inhibitor of EGF receptor tyrosine kinase activity. Biochemical Pharmacology, 63 (12), pp. 2187-2195.

Lattmann, Eric; Sattayasai, Jintana; Billington, David C.; Poyner, David R.; Puapairoj, Prapawadee; Tiamkao, Siriporn; Airarat, Wanchai; Singh, Harjit; Offel, Michael and Poyner, David Synthesis and evaluation of N1-substituted-3-propyl-1,4-benzodiazepine-2-ones as cholecystokinin (CCK2) receptor ligands. Journal of Pharmacy and Pharmacology, 54 (6), pp. 827-834.

Hay, D.L.; Conner, A.C.; Howitt, S.G.; Takhshid, M.A.; Simms, J.; Mahmoud, K. and Poyner, David The pharmacology of CGRP-responsive receptors in cultured and transfected cells. Peptides, 25 (11), pp. 2019-2026.

Hay, Debbie L.; Conner, Alex C.; Howitt, Stephen G.; Smith, David M. and Poyner, David The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. Journal of Molecular Neuroscience, 22 (1-2), pp. 105-113.

Hay, Debbie L. and Poyner, David The preclinical pharmacology of BIBN4096BS, a CGRP antagonist. Cardiovascular Therapeutics, 23 (1), pp. 31-42.

Howitt, Stephen G. and Poyner, David The selectivity and structural determinants of peptide antagonists at the CGRP receptor of rat, L6 myocytes. British Journal of Pharmacology, 121 (5), pp. 1000-1004.

This list was generated on Thu Nov 23 00:59:32 2017 GMT.